How Many Diseases Is Triple Negative Breast Cancer: The Protagonism of the Immune Microenvironment

ESMO Open - United Kingdom
doi 10.1136/esmoopen-2017-000208
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

The Immune Microenvironment of Breast Cancer Progression

Cancers
Cancer ResearchOncology
2019English

Triple-Negative Breast Cancer

2018English

Serum Amyloid a Predisposes Inflammatory Tumor Microenvironment in Triple Negative Breast Cancer

Oncotarget
Oncology
2019English

Where Do the Immune Checkpoint Inhibitors Stand in the Management of Triple Negative Breast Cancer?

Immunotherapy
OncologyAllergyImmunology
2018English

Triple Negative Breast Cancer: Breast Cancer Research in Evolution

Breast Disease
MedicineCancer ResearchOncology
2011English

Triple Negative Breast Cancer: Heterogenous Disease

REVIEWS IN ONCOLOGY
2013English

A Review of Triple-Negative Breast Cancer

Cancer Control
MedicineOncologyHematology
2010English

The Clinical Promise of Immunotherapy in Triple-Negative Breast Cancer

Cancer Management and Research
Oncology
2018English

T‑cadherin Is Associated With Prognosis in Triple‑negative Breast Cancer

Oncology Letters
Cancer ResearchOncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy